Elevra Lithium Ltd ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
$0.43next fiscal year
Monitoring Framework
Key Performance Indicators
NAL Spodumene Concentrate Production Guidance Annually185KTarget: 180,000 - 190,000 dmt
NAL Spodumene Concentrate Sales Guidance Annually180KTarget: 170,000 - 190,000 dmt
NAL Unit Operating Cost Guidance Annually870Target: US$860 - US$880/dmt
Quarterly Spodumene Concentrate Production Quarterly47.3K
Quarterly Spodumene Concentrate Sales Quarterly55.5K
Watch Items
- NAL Expansion Stage 1 CommissioningTrigger: Mid-CY2027Action: Monitor construction progress, equipment delivery, and initial throughput ramp-up to ensure the targeted 15-20% capacity increase is achieved on schedule.
- Ewoyaa Lithium Project Divestment ClosingTrigger: Q1 FY2027Action: Track Ghanaian regulatory approvals and the receipt of the US$71 million cash proceeds from Zhejiang Huayou Cobalt.
- Moblan Lithium Project Pre-Development and PermittingTrigger: Completion of Environmental and Social Impact Assessment (ESIA)Action: Monitor progress of environmental permitting and social impact assessments to advance the project toward a Final Investment Decision (FID).
Research as of 19 Jun 2026